Left Ventricular Global Longitudinal Strain as a Predictor of Outcomes in Patients with Heart Failure with Secondary Mitral Regurgitation: The COAPT Trial
Affiliation:
1. MedStar Health Research Institute, Washington, District of Columbia;2. Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands;3. Georgetown University, Washington, District of Columbia;4. Baylor University Medical Center, Baylor Heart and Vascular Institute, Dallas, Texas;5. Los Robles Regional Medical Center, Thousand Oaks, California;6. Bakersfield Heart Hospital, Bakersfield, California;7. Division of Cardiology, University of Virginia, Charlottesville, Virginia;8. The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York;9. Clinical Trials Center, Cardiovascular Research Foundation, New York, New York;10. Cleveland Clinic, Cleveland, Ohio;11. Advanced Heart Failure and Cardiac Transplantation Section, Vanderbilt Heart and Vascular Institute, Nashville, Tennessee;12. Division of Cardiovascular Medicine, The Ohio State University Medical Center, Columbus, Ohio;13. Baylor Scott & White Health, Plano, Texas;1. MedStar Health and Vascular Institute, MedStar Washington Hospital Center, Washington, District of Columbia;2. Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia;3. Cardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland;4. University of Chicago, Medical Center, Chicago, Illinois;5. MedStar Health Research Institute at MedStar Washington Hospital Center, Washington, District of Columbia;1. Ultrasound Examination Center, Tokushima University Hospital, Tokushima, Japan;2. Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan;3. Department of Community Medicine for Cardiology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
